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Abstract A truncated human Na+/glucose cotransporter (C5,
residues 407^664) was expressed and purified from Escherichia
coli using a GST fusion vector and glutathione affinity
chromatography. The truncated transporter (C5) was cleaved
from GST-C5 by Factor Xa proteolysis and purified by gel
filtration chromatography. Up to 1 mg of purified GST-C5 was
obtained from 1 l bacterial culture. Reconstitution of both GST-
C5 and C5 proteins into lipid vesicles resulted in 2.5-fold higher
initial uptake rates of [3H]D-glucose into C5-proteoliposomes
than into liposomes. Transport was stereospecific, saturable, and
inhibited by phloretin. These properties are similar to those
obtained for C5 in Xenopus laevis oocytes, and provide additional
evidence that the five C-terminal transmembrane helices in
SGLT1 form the sugar translocation pathway.
z 1999 Federation of European Biochemical Societies.
Key words: Human SGLT1; GST fusion protein;
Puri¢cation; Reconstitution
1. Introduction
SGLT1 is the archetype of a large family of integral mem-
brane proteins with mammalian, bacterial, yeast, insect and
nematode origin which transport a wide variety of substrates
(sugars, inositol, proline, panthotenate, iodide, urea, etc.). The
structural prediction for the primary amino acid sequences of
these transporters correlates with the experimentally deter-
mined topology of the human Na/glucose cotransporter,
SGLT1 [1], which includes 14 transmembrane K-helices. The
region of highest di¡erence in the amino acid sequences
among the cotransporters is located in their carboxy-terminal
domain [2]. Replacement of the C-terminus of the low a⁄nity
glucose transporter SGLT2 with the corresponding sequence
of the high a⁄nity SGLT1 in an SGLT2/SGLT1 chimera
increased 10-fold the a⁄nity for KMDG and like SGLT1
the chimera transported D-galactose and 3-O-methyl-glucose
[3]. In addition, expression of the ¢ve C-terminal helices of
SGLT1 (C5, residues 407^664) in Xenopus laevis oocytes ex-
hibited a sugar uniporter phenotype [4]. Furthermore, muta-
tion of glutamine 457 residing in C5 to arginine (Q457R)
causes glucose-galactose-malabsorption by blocking sugar
translocation [5]. In this study, human C5 was expressed as
a fusion protein in Escherichia coli and puri¢ed by a⁄nity and
gel ¢ltration chromatography. Functional reconstitution of C5
as well as the fusion protein (GST-C5) in proteoliposomes
revealed similar transport characteristics as described for C5
when expressed in Xenopus oocytes [4].
2. Materials and methods
2.1. Construction of the fusion GST-C5 plasmid
An 800 bp NcoI/NcoI fragment, positions 1218-2030 from the hu-
man SGLT1 (hSGLT1) clone [6] was isolated, and its 3P-ends ‘¢lled
in’ with Klenow fragment. This fragment encodes amino acids M407^
A664 and includes the last ¢ve transmembrane helices (C5) of
hSGLT1. The vector pGEX5X-1 (Pharmacia Biotech) containing
the gene for the glutathione S-transferase was linearized with EcoRI
and also treated with Klenow fragment. After a blunt-end ligation,
the recombinant pGEX5X-1/C5 plasmid encoded the fusion protein
GST-C5. The DNA construct was veri¢ed by double stranded DNA
sequencing using the chain termination method [7].
One l of LB medium with 100 mg ampicillin was inoculated with
10 ml of an overnight culture of E. coli BL21 cells transformed with
pGEX5X-1/C5. Cells were grown at 30‡C until reaching an optical
density (OD600) of 0.7^0.8 when expression of GST-C5 was induced
by 0.3 mM IPTG. Cells were incubated for an additional 3 h, then
harvested by pelleting at 3500Ug (20 min, 4‡C).
2.2. Puri¢cation of GST-C5
Cell pellets (4^5 g) were resuspended in 30 ml Bu¡er 1 (50 mM Tris-
HCl, pH 8; 5 mM EDTA; 50 mM NaCl, supplemented with protease
inhibitor cocktail, Sigma) and lysed by sonication with a tip sonicator
(Sonic Dismembrator model 550, Fisher Scienti¢c). Large cell debris
and unbroken cells (P1, see Fig. 1A) were separated by low speed
centrifugation (3500Ug for 20 min, 4‡C). The membrane protein
fraction was collected by a subsequent high speed centrifugation
step (350 000Ug for 20 min, 4‡C) and membrane proteins (P2) were
solubilized in 20 ml Bu¡er 1 containing 1% Triton X-100 under con-
tinuous stirring (4 h, 4‡C). The high speed centrifugation was repeated
and the pellet re-extracted with 10 ml Bu¡er 1 containing 1% Triton
X-100 (additional 4 h at 4‡C). After a high speed centrifugation, both
supernatants containing the solubilized GST-C5 were pooled. GST-C5
was separated from P2 on 2 ml bed volume glutathione-Sepharose 4B
in a batch mode. The beads were pretreated according to the manu-
facturers protocol (Pharmacia Biotech, see also [8]). To allow com-
plete binding of the fusion protein the suspension was agitated on an
orbital shaker (3 h, 22‡C). Non-speci¢cally bound material was
washed out three times for 30 min with 5 ml PBS/1% Triton X-100
for each wash. GST-C5 was then eluted with 6 ml glutathione bu¡er
(10 mM glutathione, 50 mM Tris-HCl pH 8, 1% Triton X-100). After
addition of 1 mM CaCl2, the fusion protein was digested with 30 units
Factor Xa (16 h, 22‡C). Subsequent ultra¢ltration (Microcon YM-10,
Millipore Corp.) reduced the volume to V1 ml, removed the gluta-
thione and desalted the sample. 0.75 mg (250 Wl) of this sample (con-
taining GST, C5, undigested traces of GST-C5, Factor Xa and possi-
ble degradation products) was supplemented with 2 mM EDTA,
200 mM NaCl and loaded on a Superose 12HR 10/30 FPLC column
(Pharmacia Biotech). 400 Wl fractions each were eluted with 10 mM
HEPES-Tris pH 8, 2 mM EDTA, 200 mM NaCl, 1% Triton X-100
(or 0.15% decyl L-D-maltopyranoside) at a £ow rate of 0.2 ml/min.
Fractions containing C5 (V200 Wg) were pooled and concentrated by
ultra¢ltration.
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2.3. GST-C5 detection, protein determination, PAGE and
immunoblotting
Extraction of GST-C5 from the membrane was monitored by meas-
uring GST activity (GST detection module, Pharmacia Biotech). Pro-
tein concentration was determined with a BCA protein assay kit
(Pierce) using bovine serum albumin as a standard. GST-C5 protein
induction, digestion and puri¢cation were followed on 12% SDS-
PAGE [9], and identi¢ed by silver staining [10] and immunoblotting.
The purity of GST-C5 (and C5) was accessed by densitometric quan-
titation of silver-stained SDS-PAGE gels using the software Image-
QuaNT (Molecular Dynamics, Inc.). On the Western blots GST-C5
was identi¢ed using anti-GST serum (Pharmacia Biotech) and an anti-
peptide antibody, 8821, against residues 602^613 of SGLT1 [11]. Both
antibodies were used at a dilution of 1:1000. Secondary antibodies for
C5 (Donkey anti-rabbit IgG peroxidase conjugate, Jackson Immuno-
research Laboratories, Inc.) and GST (alkaline phosphatase conju-
gate, Calbiochem) were used at a dilution of 1:10 000. Chemilumines-
cent signals on Hyper¢lm ECL (Amersham Pharmacia-Biotech) were
visualized using the SuperSignal Kit from Pierce (for horseradish
peroxidase substrates) or Western-Light Plus Kit from Trophix (for
alkaline phosphatase substrates).
2.4. Vesicle preparation and reconstitution
Twenty mg Cholesterol (Sigma) and 180 mg soy lecithin (Asolectin
Puri¢ed Soy Phosphatides, Associated Concentrates, Woodside, NY,
USA) were dissolved in 2 ml ethyl ether in glass vials. The solvent was
evaporated under a stream of N2 to obtain a thin layer of dry lipid.
Ether traces were removed under vacuum in a desiccator overnight.
The vials were ¢lled then with N2 and stored at 320‡C for up to
2 weeks. Before each reconstitution, the lipids were ¢rst resuspended
in 5 ml 10 mM Tris-HEPES pH 8 (¢nal concentration 40 mg/ml) and
subsequently sonicated in a N2-atmosphere in a bath type sonicator
(until the suspension became slightly clear and opaque, V1 h). Pro-
teoliposomes were formed in a 1 ml reconstitution reaction when 30 Wl
(40 mg/ml) liposomes were mixed with 970 Wl GST-C5 or C5 in Bu¡er
1/1% Triton X-100, containing 1 mM each CaCl2 and MgSO4. The
detergent was removed by Bio Beads SM2 (BioRad) pretreated ac-
cording to [12] in a ratio of 6:1 (wet weight beads:detergent, w/w).
The suspension was agitated for 16 h at 4‡C. Then the beads were
separated by ¢ltration (Evergreen Sci., Los Angeles, CA, USA). Pro-
teoliposomes were collected by centrifugation (350 000Ug for 60 min,
4‡C), washed twice with KCl bu¡er (150 mM KCl; 10 mM HEPES-
Tris, pH 7.4; 0.1 mM MgSO4 ; 0.1 mM CaCl2) and ¢nally resus-
pended in 0.5^1 ml Bu¡er 2 (2 mM KCl; 1 mM MgCl2 ; 1 mM CaCl2 ;
100 mM NaCl; 10 mM HEPES-Tris pH 7.4).
2.5. Functional assays
Downhill glucose transport into proteoliposomes was measured by
using [3H]D-glucose (speci¢c activity 33.9 Ci/mmol, NEN) as a sub-
strate. Uptakes of 3 WM [3H]D-glucose into control liposomes or pro-
teoliposomes were started by mixing equal volumes (20 Wl) of washed
and resuspended control liposomes (or proteoliposomes containing
GST-C5 or C5) with the radioactive glucose solution. After the indi-
cated time periods, reactions were stopped by addition of 1 ml ice-
cold Bu¡er 2 and passed through nitrocellulose ¢lters (22 Wm, Milli-
pore Corp.). The ¢lters were washed with 5 ml Bu¡er 2, dissolved in
1 ml ethyl acetate and assayed by liquid scintillation counting. Each
point in the graphs of Figs. 2^4 represents mean of triplicate measure-
ments during the same experiment. Similar experiments were repeated
2^3 times.
3. Results
C5 tagged with glutathione S-transferase was expressed in
BL21 E. coli cells. The puri¢cation steps of C5 are summar-
ized in Fig. 1A and illustrated in a Western blot (left panel)
and a silver-stained SDS-PAGE (right panel) in Fig. 1B. The
induction of the fusion GST-C5 protein (V55 kDa) could
only be detected on Western blots (lanes 3/+, Fig. 1B) but
not on silver-stained gels, indicating its low expression in the
bacterial cells. The two minor bands on the Western blot
detected with the speci¢c for C5 antibody (at 45 and 25 kDa,
lanes + and P2, Fig. 1B) probably correspond to proteolytic
fragments of GST-C5. These were eliminated after the a⁄nity
chromatography puri¢cation of GST-C5 (lane GST-C5, West-
ern blot, Fig. 1B). As determined by the densitometric quan-
titation of the silver-stained SDS-PAGE gels (Fig. 1B), GST-
C5 accounted for 90% of the protein. The contaminant bands
Fig. 1. A: A⁄nity puri¢cation of C5 tagged with glutathione S-
transferase. E. coli BL21 cells expressing GST-C5 were collected and
resuspended in Bu¡er 1. Cells were lysed by sonication and the de-
bris and unlysed cells (P1) were separated by low speed centrifuga-
tion. The membrane protein fraction (P2) was obtained by high
speed centrifugation of the S1 supernatant. The membrane proteins
in the pellet P2 were solubilized with 1% Triton X-100 (80 mg mem-
brane proteins/l culture). The corresponding to P2 supernatant (S2)
contained 240 mg soluble protein/l culture. The extracted membrane
proteins from P2, containing GST-C5, were added to glutathione-Se-
pharose 4B beads. Non-speci¢cally bound proteins were washed out
from the matrix and 1.5 mg GST-C5 was eluted with glutathione
bu¡er (GST-C5). The GST a⁄nity tag was cleaved from GST-C5 by
digestion with Factor Xa and concentrated by ultra¢ltration. The ¢-
nal puri¢cation step included gel ¢ltration on a Superose 12HR col-
umn (C5). B: 12% SDS-PAGE with BL21, GST-C5 and C5 proteins.
Western blot (left panel) illustrating di¡erent stages of the puri¢ca-
tion procedure. GST-C5, C5 and GST are depicted by arrows.
Lanes 3/+, 5 Wg of non-induced/IPTG-induced E. coli cell proteins;
P2, 5 Wg solubilized membrane proteins; GST-C5, 2 Wg eluted GST-
C5 ; C5, 2 Wg puri¢ed C5 after digestion with Factor Xa, probed
with antibody 8821; GST, same as C5 lane, but re-probed with
anti-GST. Right panel: corresponding silver-stained gel. Protein
amounts loaded were 2 times higher than on the Western blot. Mo-
lecular mass markers (Novex, San Diego, CA, USA) are indicated
in kDa and correspond to the left and right panels of the ¢gure.
FEBS 22731 6-10-99
M. Panayotova-Heiermann et al./FEBS Letters 459 (1999) 386^390 387
(10% of the total protein) were not immunoreactive with the
antibodies.
Of all non-ionic detergents tested: decyl-L-D-maltopyrano-
side (DEM), octyl-L-D-glucopyranoside (OG), 3-[(-Cholami-
dopropyl)dimethyl-amino]1-propanesulfonate) (CHAPS) and
Triton X-100, GST-C5 was best solubilized and most active
in 1% Triton X-100 (lanes P2, Fig. 1B). After a⁄nity puri¢-
cation of GST-C5 on glutathione-Sepharose 4B beads (lanes
GST-C5, 1.5 mg/l culture) C5 was released from GST by di-
gestion with Factor Xa (lanes C5). Several protocols for the
¢nal separation of GST from C5 were tested. Once the gluta-
thione S-transferase was released from the fusion protein, it
associated tightly with C5. For example, GST revealed similar
chromatography characteristics to C5 on an ion exchange col-
umn (Resource Q, Pharmacia Biotech). When we used the
Triton X-114 phase separation method [13] GST preferentially
partitioned into the detergent-depleted phase as expected, but
C5 also partially distributed in this phase, causing signi¢cant
loss of C5.
The ¢nal procedure adopted was gel ¢ltration chromatog-
raphy on a Superose 12HR 10/30 FPLC column, 24 ml bed
volume (Pharmacia Biotech). Since the resolution of the
Superose 12HR was in the range between 1000 and 3U105
Da, a quantitative separation of C5 (29.2 kDa) from the GST
(26 kDa) could not be achieved. To increase the resolution
only 0.5^1 mg protein (instead of the 5 mg maximum column
capacity) in a minimal volume (250 Wl) was loaded per run.
The quality of the eluted and pooled fractions is illustrated in
Fig. 1B, lane C5 (containing 5 Wg C5). The intensities of the
only two present bands in the lane according to the densito-
metric scan were 42% for C5 and 58% for GST. Note that
GST runs as an intensively stained band at 26 kDa whereas
C5 is weakly stained and appears more di¡use. The same
e¡ect was observed while monitoring the Factor Xa digestion
of the fusion protein. Although the molar ratio of GST to C5
in this case should be 1, GST always stained much more
intensely. This causes an overestimate in the GST contamina-
tion in the puri¢ed C5 (Fig. 1B). The yield of puri¢ed C5 was
V0.5 mg/l culture.
As shown in Figs. 2, 3 and 4, both proteins (GST-C5 and
C5) could be reconstituted in proteoliposomes while retaining
function. As a part of the fusion protein the GST moiety also
remained active with high a⁄nity for its substrates (1-chloro-
2,4-dinitrobenzene and glutathione) as determined by the GST
detection module (Pharmacia Biotech). The left panel in Fig. 2
shows that the transport of 3 WM [3H]D-glucose into GST-C5-
proteoliposomes was V10 times higher than in control lip-
osomes (1.5 þ 0.03 versus 0.16 þ 0.02 pmol/30 min). The pres-
ence of GST-C5 in the proteoliposomes is evident from the
Western blot in the right panel.
Fig. 3A illustrates the functional reconstitution of C5. C5-
proteoliposomes transported 3.5 þ 0.2 pmol/15 min, whereas
glucose uptake in control liposomes was 1.6 þ 0.1 pmol/15
min. In order to ¢nd an optimal C5-protein-to-lipid ratio
(w/w) several C5 concentrations were tested while the lipid
content was held constant (160 Wg). Highest uptakes were
obtained when 160 Wg lipids were mixed with 2 Wg protein
(protein-to-lipid ratio 1:80). This ratio was maintained in all
subsequent reconstitution experiments.
The time course of [3H]D-glucose uptake into liposomes and
C5-proteoliposomes is shown in Fig. 3B. The uptake into lip-
osomes was linear for 210 min. The uptake into proteolipo-
somes was higher than into liposomes over the course of the
Fig. 2. Reconstitution of GST-C5 in liposomes. Left panel: GST-C5
integrated into liposomes transported 1.5 þ 0.03 pmol [3H]D-glucose/
30 min of a solution containing 3 WM [3H]D-glucose, whereas the
uptake into control liposomes for the same time was 0.16 þ 0.02
pmol. Right panel: Same amounts of liposomes and GST-C5-pro-
teoliposomes as applied for the uptakes shown in the left panel
were separated on a 12% SDS-polyacrylamide gel and electroblotted
to nitrocellulose. The Western blot was probed with antibody 8821.
Fig. 3. Reconstitution of C5 in liposomes. A: D-glucose uptake into
liposomes and Western blot. [3H]D-glucose transport (3 WM) into
C5-proteoliposomes (3.5 þ 0.2 pmol) was measured for 15 min and
was two times higher than the uptake into control liposomes
(1.6 þ 0.1 pmol). The signal at 31 kDa on the photograph in the
right panel corresponds to the reconstituted C5 protein and was ob-
tained after probing the Western blot with antibody 8821. B: Time
course of glucose uptake. Uptake of 3 WM [3H]D-glucose into C5-
proteoliposomes was followed for 0, 5, 15, 30, 90, 135 and 210 min,
when it reached 3.6 þ 0.3 pmol. In the same time period uptake by
control liposomes was linear and reached 2.2 þ 0.1 pmol.
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experiment. Uptake was linear over the ¢rst 15^30 min and
then the rate decreased with time. Regression analysis of the
uptakes into proteoliposomes over 210^780 min indicated that
the sugar uptake reached a maximum of 8^10 pmol with a
half time of approximately 300 min. In ¢ve experiments the
initial rate of glucose uptake into the proteoliposomes was
about 2.5-fold higher than into liposomes, i.e. 0.031 þ 0.003
versus 0.013 þ 0.003 pmol/min. Glucose transport into C5-pro-
teoliposomes was inhibited by phloretin with an apparent Ki
of V250 WM (Fig. 4A). The 30 min uptake (1.3 þ 0.1 pmol)
was reduced V50% by 0.25 mM phloretin (0.73 þ 0.1 pmol)
and was almost completely eliminated by addition of 0.5 mM
phloretin (0.08 þ 0.03 pmol). In three experiments with control
liposomes, glucose uptake was reduced 10^20% by 0.5 mM
phloretin.
[3H]D-glucose transport into C5-proteoliposomes was
blocked by 100 mM K-methyl-D-glucose (KMDG), but not
by 100 mM mannitol or 100 mM L-glucose (Fig. 4B). D-Glu-
cose uptake in the presence of mannitol remained unchanged
(100 þ 18%; n = 3), whereas L-glucose reduced the uptake by
19 þ 2% (n = 3) and KMDG reduced it by 90 þ 9%. D-Glucose
uptake into control liposomes was only inhibited V20% by
the addition of 100 mM KMDG, L-glucose or mannitol. 100
mM mannitol or L-glucose also did not signi¢cantly inhibit
D-glucose uptake into GST-C5-containing proteoliposomes.
For example, the 15 min uptake of [3H]D-glucose (1.41 þ 0.1
pmol) remained unchanged in 100 mM mannitol (1.45 þ 0.15
pmol) and was only reduced to 1.11 þ 0.01 pmol in 100 mM
L-glucose (not shown).
4. Discussion
In this study, we have puri¢ed functional human C5 after its
heterologous expression in E. coli. The putative sugar trans-
location domain (C5) of SGLT1 was expressed as a fusion
protein in BL21 cells, puri¢ed by a⁄nity chromatography
and gel ¢ltration and reconstituted into liposomes.
Both the GST-C5 fusion protein and C5 protein puri¢ed
from E. coli were functional when reconstituted into lipo-
somes. The sugar transport properties of reconstituted C5
were similar to those for C5 expressed in X. laevis oocytes
[4]. The C5 mediated sugar uniport into oocytes was stereo-
speci¢c, saturable and sensitive to the inhibitor phloretin (Ki
V0.5 mM). Transport of 50 WM 14C-KMDG was reduced
50% by 50 mM KMDG ([4], Fig. 3C) or 100 mM D-glucose
([4], Fig. 3D), suggesting a K0:5 of V50 or 100 mM, respec-
tively. Incorporation of the GST-C5 and C5 proteins into lipid
vesicles, as con¢rmed by Western blotting (Figs. 2 and 3A),
resulted in initial rates of D-glucose transport into the vesicles
higher than into liposomes (Figs. 2 and 3). The estimated Ki
for phloretin inhibition of D-glucose uptake in C5-proteolipo-
somes was V0.25 mM. This Ki is less than the Ki determined
for KMDG uptake into oocytes (Ki V0.5 mM, [4]), which
may be due to the di¡erent a⁄nity of C5 for the two sugar
substrates (for KKMDG0:5 V50 mM and K
Dÿglc
0:5 V100 mM). As
judged by the e¡ects of phloretin and the speci¢city of sugar
substrates (KMDG versus L-glucose and mannitol), C5 medi-
ated a stereospeci¢c and saturable sugar transport across the
lipid membrane.
The yield of fusion GST-C5 (V1 mg/l) was signi¢cantly
lower than that expected for soluble proteins (V10-fold less
than manufacturer’s description), and represented V1.2% of
the total membrane protein (P2, 80 mg, see Fig. 1A). The
lower expression level is probably due to the fact that cells
can not tolerate large amounts of the foreign protein within
their membranes and thus may be toxic to the cells. Milligram
quantities of membrane proteins have only been obtained by
overexpressing the protein in inclusion bodies, IBs [14]. Pro-
teins derived from IBs are denatured and have to be re-folded
to the native state to obtain functional protein. The presence
of the large polar cytoplasmic loop in the C5 protein decreases
the hydrophobicity of C5 and could explain the higher
amounts of GST-C5 detected in the soluble fraction S2
(0.9% from the 240 mg total S2 protein, Fig. 1B). The soluble
GST-C5 decreases the apparent yield of ¢nal C5 isolated only
from the membrane fraction (P2, Fig. 1B). Under the condi-
tions for growth (30‡C) and induction (addition of 0.3 mM
IPTG at 0.8 OD600) the amount of soluble GST-C5 was at its
minimum. While contamination of foreign proteins/degrada-
tion products during the puri¢cation of C5 was not signi¢cant
(10% of the total protein, see Fig. 1B), separation of C5 from
its fusion partner became a daunting task. The strong ten-
Fig. 4. Characteristics of C5 mediated D-glucose transport. A: Inhib-
ition. The 30 min uptake of 3 WM [3H]D-glucose by C5-proteolipo-
somes (1.3 þ 0.1 pmol, black bar) was not signi¢cantly a¡ected by
addition of 0.005 (not shown) and 0.05 mM phloretin (1.70 þ 0.15),
but inhibited to 0.73 þ 0.05 pmol by 0.25 mM phloretin or to
0.08 þ 0.03 by 0.5 mM phloretin. Control uptake in liposomes was
0.6 þ 0.03 pmol. B: Sugar substrates. The 15 min uptake of 3 WM
[3H]D-glucose by C5-proteoliposomes (black bar) was competed with
100 mM each of mannitol, L-glucose or KMDG. In order to com-
pare measurements from several di¡erent experiments, data were
normalized to the values obtained for the [3H]D-glucose uptake
(3.5 þ 0.2 pmol) over 15 min, taken as 100%. Mannitol had no e¡ect
on the uptake (100 þ 18%), whereas L-glucose and KMDG inhibited
the uptake by 19 þ 2% and 90 þ 9%, respectively. Shown is the mean
of three experiments.
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dency of both proteins to copurify was di⁄cult to be resolved.
GST also copuri¢ed during the puri¢cation procedure of an-
other transmembrane protein ^ the olfactory receptor ^ when
expressed as a fusion protein [15]. This tight association of
GST with C5 and the noticeable quantity of GST-C5 in the
soluble protein fraction indicate that the pGEX expression
system is probably not the expression system of choice for
further puri¢cation of C5.
In summary, this study demonstrates that a human trun-
cated transporter (C5) may be overexpressed in E. coli, puri-
¢ed to homogeneity, and reconstituted into proteoliposomes
in its functional form. The transport properties of the recon-
stituted protein resemble those previously reported for C5 ex-
pressed in X. laevis oocytes, and this provides additional evi-
dence that the C-terminal ¢ve transmembrane helices form the
sugar translocation pathway through the Na/glucose co-
transporter. The GST fusion system provides a fair yield of
puri¢ed recombinant protein (up to 1 mg per l of culture, 90%
purity). However, as reported for another membrane protein,
it has proven di⁄cult to separate C5 from GST, thereby limit-
ing the utility of the system for biochemical and structural
studies of the transporter. Our future approach will include
overexpression of the transporter in E. coli and puri¢cation of
C5 (and SGLT1) using Ni a⁄nity chromatography. This has
been recently demonstrated for another member of the Na/
glucose cotransporter family, the Na/proline transporter of
E. coli [16].
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